These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16361651

  • 1. Randomized phase II studies and their ethics.
    Abratt RP, Reece WH, Enas NH, Stephens R.
    J Clin Oncol; 2005 Dec 20; 23(36):9443. PubMed ID: 16361651
    [No Abstract] [Full Text] [Related]

  • 2. The ethics of early stopping rules: who is protecting whom?
    Cannistra SA.
    J Clin Oncol; 2004 May 01; 22(9):1542-5. PubMed ID: 15117977
    [No Abstract] [Full Text] [Related]

  • 3. The ethics of early stopping rules.
    Pater J, Goss P, Ingle J, Shelley W, Shepherd L.
    J Clin Oncol; 2005 Apr 20; 23(12):2862-3; author reply 2863-4. PubMed ID: 15838002
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What must research subjects be told regarding the results of completed randomized trials?
    Markman M.
    IRB; 2004 Apr 20; 26(3):8-10. PubMed ID: 15281194
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Newer phase II trial designs gaining ground.
    Benowitz S.
    J Natl Cancer Inst; 2007 Oct 03; 99(19):1428-9. PubMed ID: 17895467
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The sex kitten of bioethics? Research ethics comes of age.
    Wells RJ.
    Hastings Cent Rep; 2008 Oct 03; 38(5):6-7; author reply 7. PubMed ID: 18947128
    [No Abstract] [Full Text] [Related]

  • 14. Phase II trials in mesothelioma: an increasing challenge.
    Nowak AK.
    Lung Cancer; 2005 Oct 03; 50(1):87-90. PubMed ID: 16026892
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The design and use of cluster randomised controlled trials in evaluating injury prevention interventions: part 1. Rationale, design and informed consent.
    DiGuiseppi C, Coupland C.
    Inj Prev; 2010 Feb 03; 16(1):61-7. PubMed ID: 20179039
    [No Abstract] [Full Text] [Related]

  • 17. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
    Ratain MJ, Karrison TG.
    Clin Cancer Res; 2007 Feb 01; 13(3):781-2. PubMed ID: 17289865
    [No Abstract] [Full Text] [Related]

  • 18. Appropriate informed consent, then randomization is the only ethical way!
    Maffulli N, Bridgman S, Brooks N, Walley GD.
    Arthroscopy; 2007 Feb 01; 23(2):229; author reply 229-30. PubMed ID: 17276236
    [No Abstract] [Full Text] [Related]

  • 19. Pitfalls of using composite primary end points in the presence of competing risks.
    Mell LK, Jeong JH.
    J Clin Oncol; 2010 Oct 01; 28(28):4297-9. PubMed ID: 20713860
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.